SE0602280L - Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms - Google Patents

Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms

Info

Publication number
SE0602280L
SE0602280L SE0602280A SE0602280A SE0602280L SE 0602280 L SE0602280 L SE 0602280L SE 0602280 A SE0602280 A SE 0602280A SE 0602280 A SE0602280 A SE 0602280A SE 0602280 L SE0602280 L SE 0602280L
Authority
SE
Sweden
Prior art keywords
delayed
procedures
dosage forms
release oral
dose dumping
Prior art date
Application number
SE0602280A
Other languages
Swedish (sv)
Inventor
Gayatri Sathyan
Nipun Davar
Gemma Casadevall
Linda Hearney Pors
Jayne Hastedt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0601589A external-priority patent/SE0601589L/en
Application filed by Alza Corp filed Critical Alza Corp
Priority to SE0602280A priority Critical patent/SE0602280L/en
Publication of SE0602280L publication Critical patent/SE0602280L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
SE0602280A 2005-10-31 2006-10-30 Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms SE0602280L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0602280A SE0602280L (en) 2005-10-31 2006-10-30 Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73199505P 2005-10-31 2005-10-31
US80201706P 2006-05-18 2006-05-18
SE0601589A SE0601589L (en) 2005-10-31 2006-07-20 Administration of opioids
US83704906P 2006-08-11 2006-08-11
SE0602280A SE0602280L (en) 2005-10-31 2006-10-30 Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms

Publications (1)

Publication Number Publication Date
SE0602280L true SE0602280L (en) 2007-05-01

Family

ID=38091655

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602280A SE0602280L (en) 2005-10-31 2006-10-30 Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms

Country Status (1)

Country Link
SE (1) SE0602280L (en)

Similar Documents

Publication Publication Date Title
IL268462A (en) Dosage forms of risedronate
HU0600816D0 (en) Method of alcohol-induced dose dumping for opioid sustained release oral dosage forms
HK1248521A1 (en) Oral therapeutic compound delivery system
IL206159A0 (en) Oral pharmaceutical dosage forms
ME01550B (en) Pharmaceutical dosage forms
PT2046298T (en) Pharmaceutical dosage form containing pharmaceutically acceptable solubilizing composition
IL193727A0 (en) Dosage forms for administering combinations of drugs
HRP20130344T1 (en) Buprenorphine wafer for drug substitution therapy
EP1750674A4 (en) Microparticles for oral delivery
EP2007397A4 (en) Solid oral dosage form containing an enhancer
IL179456A0 (en) Dosage form for delivery of multiple drug forms
EP1809291A4 (en) Pharmaceutical compositions for transdermal delivery
ZA200803152B (en) Oramucosal pharmaceutical dosage form
GB0616703D0 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
GB0403808D0 (en) Films for use as dosage forms
GB0612326D0 (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
ZA200804734B (en) Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
SE0602280L (en) Procedures for reducing alcohol-induced dose dumping for delayed-release oral opioid dosage forms
PL373776A1 (en) Oral pharmaceutical compound